Median LCS

DEVICE2 trials

Sponsors

Median Technologies

Conditions

High Risk CancerLung Cancer

Unknown Phase

Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)

CompletedNCT06576232

Median TechnologiesHigh Risk Cancer

Start: 2022-09-21End: 2024-08-21Updated: 2024-08-28

Retrospective Clinical Trial Comparing Radiologists' Diagnosis Accuracy in Lung Cancer Screening Population With and Without the Help of an AI/ML Tech-based SaMD

CompletedNCT06751576

Median TechnologiesHigh Risk Cancer, Lung Cancer

Start: 2022-09-21End: 2025-03-12Updated: 2025-05-06